Both these linked articles have made the rounds before; I've posted them myself here or on some related blog. Both are excellent reviews of EV architectures, but NEITHER IN ANY WAY supports your contention that 48VMH development is a boon for Lynas. At least try to stick to defending the point you're trying so desperately to make.
The first article offers nothing.
The second article contains a lengthy list of targets for electrification (hence potential Nd-Pr targets) which is worth noting.
"Depending on the vehicle application, these components can be electrified and plugged in the 48V network:
However, what you are forgetting is the fact that a number of these are also required in a BEV, even more of them on a PHEV. Really only two and a half of these items are on a mild hybrid but not on a BEV: the engine oil pump, engine coolant pump and the mild hybrid transmission oil pump (which will be much bigger than the gearbox coolant pump on an EV).
- engine oil pump
- engine vacuum pump
- transmission oil pump
- engine water pump
- A/C compressor
- intake air compressor
- engine coolant heaters"
So your mild hybrids delete the 2-4 large PM traction motors required by a BEV and only add a small integrated starter motor and two and half little pumps that might be PM-free. Pump that for all it's worth; it still looks like a net loss to me.
Add the complexity of a hybrid with gas station trips and oil changes and suddenly your crazy chimera isn't so attractive. Have you ever even driven an EV, I have to ask?
Still don't understand why someone with your obvious intelligence would buy into Lynas if Mild Hybrids were the future you envision. Yet here you are. smh.
- Forums
- ASX - By Stock
- LYC
- 1.01 48VMH
1.01 48VMH, page-2
-
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$7.15 |
Change
0.010(0.14%) |
Mkt cap ! $6.683B |
Open | High | Low | Value | Volume |
$7.14 | $7.27 | $7.12 | $40.32M | 5.616M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 9062 | $7.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.16 | 6000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 9062 | 7.150 |
1 | 12301 | 7.140 |
2 | 40688 | 7.130 |
4 | 22140 | 7.120 |
3 | 12581 | 7.110 |
Price($) | Vol. | No. |
---|---|---|
7.160 | 6000 | 1 |
7.170 | 3476 | 2 |
7.200 | 15533 | 3 |
7.210 | 13341 | 2 |
7.220 | 12301 | 1 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online